SCHEMBL7970178

SCHEMBL7970178

CC(=O)N1CCN(N)CC1C(=O)NCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
PKM P14618 1/20 0.49
CYP2C19 P33261 1/20 0.49
F2 P00734 1/20 0.48
ALDH1A1 P00352 3/20 0.46
XIAP P98170 3/20 0.46
NPSR1 Q6W5P4 2/20 0.45
USP2 O75604 1/20 0.45
HPGD P15428 1/20 0.45
MC4R P32245 1/20 0.45
FKBP1A P62942 3/20 0.45
NPC1 O15118 1/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7970571 0.83 CYP3A4 (0.47) CYP3A4CYP2C9PKMCYP2C19F2
SCHEMBL8096850 0.81 CYP3A4 (0.72) CYP3A4CYP2C9PKMCYP2C19F2
SCHEMBL27394992 0.81 CYP3A4 (0.72) CYP3A4CYP2C9PKMCYP2C19F2
SCHEMBL7975161 0.76 ALDH1A1 (0.51) CYP3A4CYP2C9PKMCYP2C19F2
SCHEMBL14969584 0.72 RAB9A (0.53) ALDH1A1MC4R
SCHEMBL23134470 0.72 F12 (0.46) CYP3A4CYP2C9PKMCYP2C19F2
SCHEMBL14963205 0.71 ALDH1A1 (0.49) CYP3A4CYP2C9PKMCYP2C19ALDH1A1
SCHEMBL21854806 0.71 TACR1 (0.51) CYP3A4CYP2C9PKMCYP2C19NPSR1
SCHEMBL10144672 0.69 CYP3A4 (0.64) CYP3A4CYP2C9PKMCYP2C19F2
SCHEMBL7302729 0.69 CYP3A4 (0.64) CYP3A4CYP2C9PKMCYP2C19F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291464-B1 POTENTIATION OF THE CHOLINERGIC ACTIVITY; THERAPEUTIC TREATMENT OF AMNESIA, DEMENTIA OR SENILE DEMENTIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-09-18 US disclosed